Medical Marijuana for Alzheimer's Disease in Florida
Progressive neurodegenerative disease causing memory loss and cognitive decline.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
Alzheimer's Disease is the most common form of dementia, affecting approximately 6.7 million Americans aged 65 and older. It is a progressive neurodegenerative condition characterized by worsening memory loss, confusion, disorientation, personality changes, difficulty with language and problem-solving, and ultimately the inability to carry out basic daily tasks. Alzheimer's is caused by abnormal accumulation of amyloid plaques and tau tangles in the brain, leading to neuron death and brain atrophy.
The disease progresses through stages — from mild cognitive impairment to severe dementia requiring full-time care. Current FDA-approved treatments include cholinesterase inhibitors and memantine, which can temporarily slow symptom progression in some patients but do not alter the underlying disease course. Behavioral symptoms including agitation, aggression, anxiety, depression, and sleep disturbances are particularly challenging and often lead to antipsychotic use with its associated risks.
How Medical Cannabis May Help
Preclinical research suggests cannabinoids may have neuroprotective properties relevant to Alzheimer's pathology — including the ability to reduce amyloid plaque formation, decrease neuroinflammation, and promote neurogenesis (the growth of new brain cells). While these disease-modifying effects require further clinical validation, medical cannabis already offers meaningful symptom management benefits for Alzheimer's patients. Cannabis can reduce agitation and aggression (often the most distressing behavioral symptoms for patients and caregivers), improve appetite and prevent weight loss, improve sleep quality, and reduce anxiety and depression. THC-containing preparations may help with appetite and sleep, while CBD-dominant formulations can address agitation and anxiety without the cognitive impairment risks of antipsychotic medications. Dr. Stratt works closely with patients and their caregivers to develop appropriate, carefully monitored treatment plans.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring a valid Florida ID and neurology records confirming Alzheimer's diagnosis, cognitive assessment results, current medication list. A caregiver should accompany the patient to the evaluation.
Get Certified for Alzheimer's Disease
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.